In recent decades, the role of RB1 loss and the inactivation or dysregulation of RBp function by RB-associated proteins have been implicated in many cancer types, e.g., melanomas, osteosarcomas, small-cell lung cancer, and several mesenchymal tumors [10]. This evidence concerns the gene RB1 and mesenchymal cell neoplasm.